VRTX   $492.38  -1.36% Market Closed After Close 490.0 -0.48%

Vertex Pharmaceuticals Incorporated
Total Cash 6.52B
totalCashPerShare 25.318
EBITDA 4.45B
Total Debt 1.70B
quickRatio 2.083
currentRatio 2.468
Total Revenue 10.63B
debtToEquity 10.894
Revenue/Share 41.185
ROA 0.12051
ROE -0.029849999
grossProfits
freeCashflow
operatingCashflow
earningsGrowth 0.01
revenueGrowth 0.116
grossMargins 0.56352
ebitdaMargins 0.41859
operatingMargins 0.40824002
profitMargins -0.045149997
enterpriseValue 124.00B
forwardPE 28.745256
floatShares 256.93M
sharesOutstanding 257.70M
sharesShort 4.29M
sharesShortPriorMonth 4.34M
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.00%
heldPercentInstitutions 0.95%
Short Ratio help_outline 4.16%
shortPercentOfFloat 0.02%
impliedSharesOutstanding
bookValue 60.655
Price To Book help_outline 8.24
earningsQuarterlyGrowth 0.01
netIncomeToCommon -479.80M
trailingEps -1.90%
forwardEps 17.39%
enterpriseToEbitda 27.88
lastDividendValue
lastDividendDate
currentQuarterEstimate 4.08 4Q 2024
institutionsCount 2216
lastUpdated Nov. 6, 2024, 4:23 p.m.